Speaker Profile

M.D., Senior Director, BD, Rady Children’s Institute for Genomic Medicine

Biography
Dr. Nofsinger has been helping to better understand genomics and to catalyze harnessing the power of genomic technology to advance precision healthcare for more than 20 years. Russell conducted his PhD and postdoctoral training at the University of California, San Diego and the Salk Institute. Following his scientific training, Dr. Nofsinger served in a variety of commercial roles for several genomics technology companies. During this tenure, he developed clinically focused businesses supporting proprietary test development across a wide range of indications. Through his experience creating and expanding applied markets for cutting-edge genomics technologies, Russell developed a passion for driving clinical implementation and broadening access to clinical genomics technologies.


Clinical Dx showcase:
Rady Children’s Institute for Genomic Medicine®

Rady Children’s Institute for Genomic Medicine® is transforming neonatal and pediatric healthcare by offering the fastest delivery of rapid Whole Genome Sequencing™ to enable prompt diagnosis and targeted treatment of critically ill newborns and children in intensive care.

Changing Lives in Real Time with rWGS
Rady Children’s Institute for Genomic Medicine® performs the world’s fastest rapid Whole Genome Sequencing™, diagnosis, and reporting to drive Rapid Precision Medicine and unleash the power of rWGS to end the therapeutic odyssey for children suffering from rare genetic disease.

 Session Abstract – PMWC 2022 Silicon Valley

Track 6, June 28-30


The PMWC 2022 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.

- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Nerodegenerative